{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T22:52:49Z","timestamp":1773355969028,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,12]]},"DOI":"10.7759\/cureus.105094","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:07:51Z","timestamp":1773317271000},"source":"Crossref","is-referenced-by-count":0,"title":["Intraoperative Heparin Resistance and Internal Carotid Artery Occlusion After Andexanet Alfa Reversal During Endovascular Treatment of a Ruptured Cerebral Aneurysm: A Case Report"],"prefix":"10.7759","author":[{"given":"Shin","family":"Kawamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misao","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.057844","article-title":"Final study report of andexanet alfa for major bleeding with factor Xa inhibitors","volume":"147","author":"Milling TJ Jr","year":"2023","unstructured":"Milling TJ Jr, Middeldorp S, Xu L, et al.. Final study report of andexanet alfa for major bleeding with factor Xa inhibitors. Circulation. 2023, 147:1026-38. 10.1161\/CIRCULATIONAHA.121.057844","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.cn-001997","article-title":"Acute internal carotid artery occlusion following administration of Andexanet alfa for the reversal of direct factor Xa inhibitors in patients with cerebral hemorrhage","volume":"64","author":"Uemura S","year":"2024","unstructured":"Uemura S, Takasugi J, Ohara N, Koyanagi M, Ohta T, Kawamoto M. Acute internal carotid artery occlusion following administration of Andexanet alfa for the reversal of direct factor Xa inhibitors in patients with cerebral hemorrhage. Rinsho Shinkeigaku. 2024, 64:730-5. 10.5692\/clinicalneurol.cn-001997","journal-title":"Rinsho Shinkeigaku"},{"key":"ref3","article-title":"Direct Healthcare Professional Communication (DHPC): Ondexxya (Andexanet alfa): Avoid Use of Andexanet Prior to Heparinization","author":"European Medicines Agency","year":"2023","unstructured":"European Medicines Agency. Direct Healthcare Professional Communication (DHPC): Ondexxya (Andexanet alfa): Avoid Use of Andexanet Prior to Heparinization . EMA, Amsterdam; 2023."},{"key":"ref4","unstructured":"Japanese Society of Cardiovascular Anesthesiologists, Japanese Association for Thoracic Surgery, Japanese Society for Cardiovascular Surgery, Japanese Society for Extracorporeal Technology. Joint statement on the perioperative use of andexanet alfa. (2025). Accessed: June 30, 2025: https:\/\/www.jscva.org\/news\/detail\/id\/296."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13768","article-title":"Preclinical safety and efficacy of andexanet alfa in animal models","volume":"15","author":"Lu G","year":"2017","unstructured":"Lu G, Hollenbach SJ, Baker DC, Tan S, Hutchaleelaha A, Curnutte JT, Conley PB. Preclinical safety and efficacy of andexanet alfa in animal models. J Thromb Haemost. 2017, 15:1747-56. 10.1111\/jth.13768","journal-title":"J Thromb Haemost"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2020.10.042","article-title":"Successful antithrombin administration in andexanet alfa-associated heparin resistance","volume":"35","author":"Apostel HJ","year":"2021","unstructured":"Apostel HJ, Winckers K, Bidar E, Schreiber JU. Successful antithrombin administration in andexanet alfa-associated heparin resistance. J Cardiothorac Vasc Anesth. 2021, 35:904-7. 10.1053\/j.jvca.2020.10.042","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-022-01573-5","article-title":"Andexanet-alfa-associated heparin resistance in the context of hemorrhagic stroke","volume":"37","author":"M\u00fcther M","year":"2022","unstructured":"M\u00fcther M, Schwindt W, Mesters RM, et al.. Andexanet-alfa-associated heparin resistance in the context of hemorrhagic stroke. Neurocrit Care. 2022, 37:372-6. 10.1007\/s12028-022-01573-5","journal-title":"Neurocrit Care"},{"key":"ref8","article-title":"","author":"Japan Stroke Association","year":"2021","unstructured":"Japan Stroke Association. Stroke Data Bank 2021. Nakayama Shoten, Tokyo; 2021. https:\/\/strokedatabank.ncvc.go.jp\/."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1253\/circj.72.909","article-title":"Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city","volume":"72","author":"Iguchi Y","year":"2008","unstructured":"Iguchi Y, Kimura K, Aoki J, Kobayashi K, Terasawa Y, Sakai K, Shibazaki K. Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city. Circ J. 2008, 72:909-13. 10.1253\/circj.72.909","journal-title":"Circ J"},{"key":"ref10","article-title":"","author":"Japanese Stroke Society","year":"2025","unstructured":"Japanese Stroke Society. Japanese Guidelines for the Management of Stroke 2021 [Revised 2025]. Kyowa Kikaku, Tokyo; 2025. https:\/\/www.jsts.gr.jp\/img\/guideline2021_kaitei2025_kaiteikoumoku.pdf."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/465167-intraoperative-heparin-resistance-and-internal-carotid-artery-occlusion-after-andexanet-alfa-reversal-during-endovascular-treatment-of-a-ruptured-cerebral-aneurysm-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:08:01Z","timestamp":1773317281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/465167-intraoperative-heparin-resistance-and-internal-carotid-artery-occlusion-after-andexanet-alfa-reversal-during-endovascular-treatment-of-a-ruptured-cerebral-aneurysm-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.105094","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,12]]}}}